Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...

Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...

Moderna and Merck are preparing to seek regulatory approval after their experimental melanoma vaccine delivered promising results in a late-stage clinical trial.

Learn what to expect during recovery after joint replacement surgery, from the first days through physical therapy and beyond ...

Prostate cancer treatments carry different risks. Dr. Fernando Bianco argues for informed decisions that balance cancer ...

In about three years, I have decided to close Papa-rin's dental office🦷, as there is no successor. Our eldest son did not ...

Seasoned legal and compliance executive brings global product launch, strategic transaction and international operational experience as Candel prepares for its planned Biologics License Application ...

In the study, pembrolizumab plus enfortumab vedotin as perioperative treatment demonstrated a statistically significant improvement in event-free survival (Efs), reducing the risk of Efs events by 47% ...

Msd announced today that the European Commission has approved pembrolizumab in combination with enfortumab vedotin, as neoadjuvant treatment and subsequently, after radical cystectomy, as adjuvant ...

A small regional pilot trial found supervised aerobic exercise before cancer surgery was well attended and caused no serious ...

What matters in prostate cancer treatment is not simply removing the cancer. How much urinary and sexual function can be ...

We follow the preparations for a major brain surgery to remove a tumor and the emotional moments leading up to the operation.